AR092278A1 - Proceso de obtencion de derivados n-acilicos de bifenil-alanina e intermediarios relacionados - Google Patents

Proceso de obtencion de derivados n-acilicos de bifenil-alanina e intermediarios relacionados

Info

Publication number
AR092278A1
AR092278A1 ARP130103068A ARP130103068A AR092278A1 AR 092278 A1 AR092278 A1 AR 092278A1 AR P130103068 A ARP130103068 A AR P130103068A AR P130103068 A ARP130103068 A AR P130103068A AR 092278 A1 AR092278 A1 AR 092278A1
Authority
AR
Argentina
Prior art keywords
formula
compound
halogen
alkyl
salt
Prior art date
Application number
ARP130103068A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR092278A1 publication Critical patent/AR092278A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/04Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/30Preparation of ethers by reactions not forming ether-oxygen bonds by increasing the number of carbon atoms, e.g. by oligomerisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Proceso enantio-selectivo para producir intermediarios útiles para la elaboración de inhibidores de NEP o pro-fármacos de los mismos, en particular de los inhibidores de NEP que comprenden una estructura base de ácido o éster de ácido g-amino-d-bifenil-a-metil-alcanoico. Reivindicación 1: Un proceso para la preparación de un compuesto de la fórmula (1), o de una sal del mismo, en donde X es halógeno, de preferencia cloro, u -O-R⁵, en donde R⁵ es alquilo C₁₋₆, de preferencia terbutilo; de preferencia en donde el compuesto de la fórmula (1) es de la fórmula (2), o una sal del mismo, en donde X es halógeno, de preferencia cloro, u -O-R⁵, en donde R⁵ es alquilo C₁₋₆, de preferencia terbutilo; el cual comprende hacer reaccionar un compuesto de la fórmula (3) en donde X es halógeno, de preferencia cloro, u -O-R⁵, en donde R⁵ es alquilo C₁₋₆, de preferencia terbutilo; de preferencia en donde el compuesto de la fórmula (3) es de la fórmula (4) en donde X es halógeno, de preferencia cloro, u -O-R⁵, en donde R⁵ es alquilo C₁₋₆, de preferencia terbutilo; con un compuesto bifenílico, de preferencia un compuesto bifenílico activado, para obtener un compuesto de la fórmula (1) o una sal del mismo, de preferencia de la fórmula (2) o una sal del mismo.
ARP130103068A 2012-08-31 2013-08-29 Proceso de obtencion de derivados n-acilicos de bifenil-alanina e intermediarios relacionados AR092278A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201210317827 2012-08-31
CN2013079565 2013-07-18

Publications (1)

Publication Number Publication Date
AR092278A1 true AR092278A1 (es) 2015-04-08

Family

ID=49080910

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130103068A AR092278A1 (es) 2012-08-31 2013-08-29 Proceso de obtencion de derivados n-acilicos de bifenil-alanina e intermediarios relacionados

Country Status (15)

Country Link
US (1) US9624163B2 (es)
EP (1) EP2890672B1 (es)
JP (1) JP6280119B2 (es)
KR (1) KR20150048133A (es)
CN (1) CN105026361B (es)
AR (1) AR092278A1 (es)
AU (1) AU2013307767B2 (es)
BR (1) BR112015004121A2 (es)
CA (1) CA2880194A1 (es)
ES (1) ES2685621T3 (es)
IN (1) IN2015DN00909A (es)
MX (1) MX2015002640A (es)
RU (1) RU2015111486A (es)
TW (1) TW201414708A (es)
WO (1) WO2014032627A1 (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014181362A1 (en) * 2013-05-09 2014-11-13 Council Of Scientific & Industrial Research A process for the preparation of 3-aryl-2-hydroxy propanoic acid compounds
WO2015037460A1 (ja) * 2013-09-10 2015-03-19 住友化学株式会社 光学活性な3-(ビフェニル-4-イル)-2-[(t-ブトキシカルボニル)アミノ]プロパン-1-オールの製造方法
CN104926704B (zh) * 2014-03-18 2019-03-05 浙江九洲药物科技有限公司 氮杂环丙烷类化合物及其制备方法
WO2015154673A1 (en) * 2014-04-10 2015-10-15 Zhaoyin Wang Novel prodrugs and combinations for treatment of hypertension and cardiovascular diseases
WO2016074651A1 (en) 2014-11-14 2016-05-19 Zentiva, K.S. A method for the preparation, isolation and purification of pharmaceutically applicable forms of ahu-377
CN105985225A (zh) * 2015-02-12 2016-10-05 博瑞生物医药(苏州)股份有限公司 一种lcz-696及其中间体的制备方法
TW201632493A (zh) 2015-02-13 2016-09-16 諾華公司 新穎方法
CN106187808A (zh) * 2015-05-08 2016-12-07 苏州鹏旭医药科技有限公司 Ahu-377的制备方法、ahu-377中间体及ahu-377中间体的制备方法
CN105017082B (zh) * 2015-07-31 2017-09-19 上海皓元医药股份有限公司 一种心衰药Entresto 关键中间体(R)‑叔丁基 (1‑([1,1`‑联苯]‑4‑基)‑3‑羟基丙烷‑2‑基)氨基甲酸酯的制备方法
CN105085322B (zh) * 2015-08-15 2017-10-03 浙江永宁药业股份有限公司 Ahu‑377中间体的制备方法及其中间体和中间体的制备方法
CN105168205A (zh) * 2015-08-18 2015-12-23 泰力特医药(湖北)有限公司 一种血管紧张素ii受体和脑啡肽酶受体双重抑制剂lcz696的制备方法
CN105330569A (zh) * 2015-09-11 2016-02-17 天台宜生生化科技有限公司 一种(r)-2-(n-叔丁氧羰基氨基)联苯丙醇的制备方法
WO2017051326A1 (en) 2015-09-23 2017-03-30 Novartis Ag New processes and intermediates useful in synthesis of nep inhibitors
CN105198775B (zh) 2015-10-10 2017-11-14 凯瑞斯德生化(苏州)有限公司 一种手性N‑Boc联苯丙氨醇的制备方法
CN105237560B (zh) * 2015-10-15 2018-07-06 上海博氏医药科技有限公司 一种lzc696中间体及其合成方法
CN105254589B (zh) * 2015-10-15 2018-07-31 上海博氏医药科技有限公司 一种制备心力衰竭药物中间体的方法
CN105348209B (zh) 2015-12-09 2017-12-26 浙江天宇药业股份有限公司 一种抗心衰药lcz696的制备方法
CN105523964B (zh) * 2015-12-09 2017-05-24 苏州楚凯药业有限公司 一种抗心衰药物中间体的制备方法
US10377697B2 (en) 2015-12-10 2019-08-13 Novartis Ag Process and intermediates
EP3386945A1 (en) 2015-12-11 2018-10-17 Zentiva, K.S. Solid forms of (2r,4s)-5-(biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2- -methylpentanoic acid ethyl ester, its salts and a preparation method
CN105585511B (zh) * 2016-01-08 2017-05-31 浙江大学 (r)‑n‑叔丁氧羰基联苯丙氨醇的制备方法
CN105820064A (zh) * 2016-04-18 2016-08-03 浙江天宇药业股份有限公司 一种联苯基丙氨醇衍生物的合成方法及中间体
CN105753741A (zh) * 2016-04-26 2016-07-13 常州制药厂有限公司 一种抗心衰药物Sacubitril中间体的制备方法
WO2017203474A1 (en) * 2016-05-27 2017-11-30 Dr. Reddy's Laboratories Limited Process for preparation of sacubutril intermediate
WO2018007919A1 (en) 2016-07-05 2018-01-11 Novartis Ag New process for early sacubitril intermediates
CN109563019A (zh) 2016-08-17 2019-04-02 诺华股份有限公司 Nep抑制剂合成的新方法和中间体
CN107778192A (zh) * 2016-08-26 2018-03-09 浙江九洲药业股份有限公司 一种n‑烷氧或苄氧羰基手性氨酸的制备方法
CN106431993B (zh) * 2016-09-14 2018-10-30 重庆市碚圣医药科技股份有限公司 一种lcz-696关键中间体的制备方法
CN106565505A (zh) * 2016-11-08 2017-04-19 重庆市碚圣医药科技股份有限公司 (r)‑3‑([1,1’‑联苯]‑4‑基)‑2‑氨基丙‑1‑醇盐酸盐的制备方法
CN106588698B (zh) * 2016-11-18 2019-01-22 凯瑞斯德生化(苏州)有限公司 一种N-Boc联苯丙氨醛的制备方法
JP7138106B2 (ja) * 2016-12-23 2022-09-15 ノバルティス アーゲー 初期サクビトリル中間体のための新規な方法
CN108238981A (zh) * 2016-12-23 2018-07-03 宁波爱诺医药科技有限公司 一种lcz-696关键中间体的制备方法
CN106946742A (zh) * 2017-03-28 2017-07-14 常州沃腾化工科技有限公司 一种三苯基氧磷含量低的沙库必曲中间体的制备方法
CN107011203B (zh) * 2017-04-28 2019-03-29 江苏阿尔法药业有限公司 一种lcz696中间体ahu-377的制备方法
CN107382779B (zh) * 2017-07-27 2020-04-17 江苏中邦制药有限公司 一种沙库必曲中间体的制备方法
CN107522628A (zh) * 2017-09-20 2017-12-29 吉尔生化(上海)有限公司 一种l‑3‑(6‑乙酰基‑2‑萘胺基)‑2‑氨基丙酸的合成方法
CN108047093A (zh) * 2017-11-29 2018-05-18 南通常佑药业科技有限公司 一种联苯基氨基丙醛化合物的制备方法
CN108047092A (zh) * 2018-01-12 2018-05-18 重庆市碚圣医药科技股份有限公司 一种lcz696中间体的合成方法
CN108191712A (zh) * 2018-01-15 2018-06-22 重庆市碚圣医药科技股份有限公司 一种lcz696关键中间体母液回收方法
CN108675943A (zh) * 2018-06-13 2018-10-19 常州亚邦制药有限公司 一种沙库巴曲关键中间体的制备方法
CN109336804B (zh) * 2018-12-21 2021-03-30 浙江工业大学 一种管道化合成沙库必曲关键中间体的方法
CN110183357B (zh) * 2019-06-13 2021-09-24 甘肃皓天医药科技有限责任公司 一种用于制备沙库比曲中间体的制备方法
CN113754565B (zh) * 2021-11-09 2022-02-22 南京威凯尔生物医药科技有限公司 一种连续流微反应器中制备沙库巴曲中间体的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1040735A (en) * 1964-07-23 1966-09-01 British Drug Houses Ltd 4-aryl-3-hydroxybutyric acid and esters, amides and salts thereof
US5587494A (en) * 1992-03-17 1996-12-24 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Practical, cost-efficient chiral synthesis of dihydrosphingosines
US5962506A (en) * 1997-07-07 1999-10-05 Pharmacopeia, Inc. Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases
WO2007025284A1 (en) * 2005-08-24 2007-03-01 Rib-X Pharmaceuticals, Inc. Triazole compounds and methods of making and using the same
EP1903027A1 (en) * 2006-09-13 2008-03-26 Novartis AG Process for preparing biaryl substituted 4-amino-butyric acid or derivatives thereof and their use in the production of NEP inhibitors
CN101362708B (zh) * 2008-09-05 2012-05-16 浙江工业大学 叔丁基-[2-(联苯-4-基)-1-(羟甲基)乙基]氨基甲酸酯的合成方法
WO2013026773A1 (en) 2011-08-19 2013-02-28 Dsm Ip Assets B.V. Synthesis of r-biphenylalaninol

Also Published As

Publication number Publication date
CA2880194A1 (en) 2014-03-06
BR112015004121A2 (pt) 2017-07-04
US9624163B2 (en) 2017-04-18
US20150210632A1 (en) 2015-07-30
WO2014032627A1 (en) 2014-03-06
AU2013307767A1 (en) 2015-02-19
KR20150048133A (ko) 2015-05-06
RU2015111486A (ru) 2016-10-20
TW201414708A (zh) 2014-04-16
CN105026361A (zh) 2015-11-04
EP2890672A1 (en) 2015-07-08
IN2015DN00909A (es) 2015-06-12
ES2685621T3 (es) 2018-10-10
CN105026361B (zh) 2018-04-03
JP6280119B2 (ja) 2018-02-14
EP2890672A4 (en) 2016-04-20
JP2015532648A (ja) 2015-11-12
MX2015002640A (es) 2015-06-24
AU2013307767B2 (en) 2016-07-28
EP2890672B1 (en) 2018-05-30

Similar Documents

Publication Publication Date Title
AR092278A1 (es) Proceso de obtencion de derivados n-acilicos de bifenil-alanina e intermediarios relacionados
CU24410B1 (es) Benzimidazol-2-aminas como inhibidores de midh1
AR106141A1 (es) Métodos e intermediarios para la preparación de derivados de ácidos biliares
CY1116987T1 (el) Συμπυκνωμενα ιμιδαζολυλιμιδαζολια ως αντιϊικες ενωσεις
CR20130129A (es) Anàlogos de buprenorfina
IN2014MN02496A (es)
GT201000211A (es) Procesos e intermediarios para la preparación de derivados de acido 5-bifenil-a-il-2-metilpentanoico
AR085155A1 (es) Procesos para preparar compuestos de quinolina y composiciones farmaceuticas que contienen dichos compuestos
MA35089B1 (fr) Inhibiteurs de la production de leucotrienes de type benzodioxane
CU24354B1 (es) Procedimiento de obtención de derivados de tetrafluoropropilmorfolina
ECSP13012519A (es) Compuestos sustituidos de benzamida
CR20150663A (es) Derivados de diazacarbazol como ligandos de tau para pet
AR088483A1 (es) Proceso para preparar derivados de quinolina
IN2014MN01521A (es)
CL2019002079A1 (es) Sales del inhibidor de pim quinasa; útiles en el tratamiento del cáncer. (divisional solicitud 201800611)
EA201992421A1 (ru) Способ получения озанимода
AR117002A2 (es) Proceso para la preparación de inhibidores de quinasa c-fms
EA201201667A1 (ru) Способ получения l-аргининовой соли периндоприла
IN2013MU03442A (es)
CR20120592A (es) Intermedios de agomelatina y métodos de preparación de estos
BR112015024859A2 (pt) processo e intermediários para a preparação de pregabalina
AR098879A1 (es) Síntesis de ent-progesterona y sus productos intermedios
UY33879A (es) Proceso para la preparación de amidas del ácido pirazol carboxílico
EA200971019A1 (ru) Способы получения (r)-2-метилпирролидина и (s)-2-метилпирролидина и их солей винной кислоты
AR093270A1 (es) METODO DE PREPARACION DE COMPUESTOS DE a-GALACTOSILCERAMIDAS

Legal Events

Date Code Title Description
FB Suspension of granting procedure